Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms Meeting Abstract


Authors: Gigoux, M.; Elf, S.; Ciboddo, M.; Zappasodi, R.; Pourpe, S.; Abdelfattah, N.; Chan, T.; Abdel-Wahab, O.; Mullally, A.; Merghoub, T.; Wolchok, J.
Abstract Title: Developing a cross-reactive heteroclitic peptide cancer vaccine targetting poorly immunogenic mutant calreticulin in myeloproliferative neoplasms
Meeting Title: 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 6
Issue: Suppl. 1
Meeting Dates: 2018 Nov 7-11
Meeting Location: Washington, DC
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2018-11-06
Start Page: 114
Language: English
PMCID: PMC6220480
PUBMED: 30400835
DOI: 10.1186/s40425-018-0422-y
PROVIDER: manual
Notes: Meeting Abstract: P156
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Timothy Chan
    317 Chan
  2. Jedd D Wolchok
    905 Wolchok
  3. Taha Merghoub
    364 Merghoub
  4. Stephane Pourpe
    12 Pourpe
  5. Mathieu Gigoux
    23 Gigoux